CDNA
CareDx Inc
获取预测
在您的设备上获取AI股票预测
关于该公司
CareDx develops molecular tests for assessing the immune system and treating kidney and heart diseases. The company specializes in transplantation, offering tests to evaluate donor-recipient compatibility for organ transplants, monitor graft status, and detect signs of rejection. CareDx also develops diagnostic tests for cardiomyopathies and hereditary diseases. The company collaborates with clinics worldwide.
立即获取AI股票预测
下载我们的AI股票预测实时应用
